Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
A Randomized Controlled Trial of Cognitive Behavioral Therapy (CBT) for Adjusting to Multiple Sclerosis (the saMS Trial): Does CBT Work and for Whom Does It Work?
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis.
Neurofilaments as biomarkers in multiple sclerosis.
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Can we safely target the WNT pathway?
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin.
Ibuprofen-induced unilateral optic neuritis.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
ATX-MS-1467 in Multiple Sclerosis
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
[Autophagy and its role in protective and damaging inflammatory response].
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »